-transparent.png){kind=logo}
Prenatal RDS-prevention is currently done by two substances: Corticosteroids and Bromhexine Metabolit VIII. The influence on fibrinolytic activity of these drugs in the fetal rat-lung was tested in vivo. The inhibitory effect against tissue-fibrinogen-activator of Beta-methason was greater than this of Bromhexine Metabolit VIII.
Related Publications
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
April 1977,
Zeitschrift fur Geburtshilfe und Perinatologie,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
January 1978,
Arzneimittel-Forschung,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
November 1975,
Archiv fur Gynakologie,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
December 2003,
American journal of obstetrics and gynecology,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
January 1973,
Nihon seirigaku zasshi. Journal of the Physiological Society of Japan,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
April 1978,
European journal of obstetrics, gynecology, and reproductive biology,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
April 1975,
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
January 1980,
Respiration; international review of thoracic diseases,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
February 1978,
Zeitschrift fur Geburtshilfe und Perinatologie,
S Haas-Denk, and
P Krieglsteiner, and
I Wriedt-Lübbe, and
W Erhardt, and
W Münnich, and
G Blümel
July 1977,
Archiv fur Gynakologie,
